These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39026319)

  • 1. Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors.
    Hu X; Dai X; Guo X; Jiang X; Li Y; Zhao H; Lu J; Li X; Jin M
    Diagn Pathol; 2024 Jul; 19(1):99. PubMed ID: 39026319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.
    Paul B; Zhao Y; Loitsch G; Feinberg D; Mathews P; Barak I; Dupuis M; Li Z; Rein L; Wang E; Kang Y
    Cancer Med; 2020 Aug; 9(16):5869-5880. PubMed ID: 32628819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical and prognostic characteristics of newly diagnosed multiple myeloma with myelofibrosis patients].
    Zhang L; Li YL; Liu YM; Liu YB; Shang BJ; Cheng W; Dong XY; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):57-62. PubMed ID: 38178769
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of bone marrow fibrosis in diffuse large B-cell lymphoma.
    Cetintepe T; Ozkan G; Kucukzeybek BP; Cetintepe L; Unal DK; Solmaz S; Aygun K; Acar AG; Bener S; Çallı AO; Payzın KB
    Int J Lab Hematol; 2024 Jun; 46(3):523-530. PubMed ID: 38361314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis].
    Li HL; Ru K; Sun Q; Li ZQ; Zhang HJ; Ma Y; Xian M; Qiu LG; Liu EB
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):327-331. PubMed ID: 28468039
    [No Abstract]   [Full Text] [Related]  

  • 6. Histomorphology of multiple myeloma on bone marrow biopsy.
    Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
    Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis.
    Gianelli U; Vener C; Bossi A; Cortinovis I; Iurlo A; Fracchiolla NS; Savi F; Moro A; Grifoni F; De Philippis C; Radice T; Bosari S; Lambertenghi Deliliers G; Cortelezzi A
    Mod Pathol; 2012 Sep; 25(9):1193-202. PubMed ID: 22627739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of bone marrow fibrosis in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation analysis of polyclonal plasma cell proportion in the bone marrow with clinical characteristics of patients with newly diagnosed multiple myeloma].
    Long XL; Wang XR; An N; Liu SY; Li Z; Li CH; Mu W; Wang D; Li CR
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):475-480. PubMed ID: 38964922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis.
    Kröger N; Zabelina T; Alchalby H; Stübig T; Wolschke C; Ayuk F; von Hünerbein N; Kvasnicka HM; Thiele J; Kreipe HH; Büsche G
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):812-5. PubMed ID: 24589549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bone marrow histology in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Indian J Cancer; 2009; 46(1):40-5. PubMed ID: 19282565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
    Schmidt U; Ruwe M; Leder LD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model.
    Lee BH; Park Y; Kim JH; Kang KW; Lee SJ; Kim SJ; Kim BS
    Sci Rep; 2020 Jul; 10(1):12641. PubMed ID: 32724129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis.
    Jamieson C; Hasserjian R; Gotlib J; Cortes J; Stone R; Talpaz M; Thiele J; Rodig S; Pozdnyakova O
    J Transl Med; 2015 Sep; 13():294. PubMed ID: 26357842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
    Marcinek J; Plank L; Szépe P; Balhárek T
    Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10].
    Zhao JT; Jiang XY; Yang C; Chen M; Lan XL; Du JH; Zhou DB; Zhuang JL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):295-301. PubMed ID: 33979973
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
    Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
    Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.